Digestive Remedies in Belgium

 Published On: Sep, 2016 |    No of Pages: 36 |  Published By: Euromonitor | Format: PDF
Things will work out better¯ was the main leitmotiv of players in digestive remedies; without evidence of real recovery of the category, however. From the middle of 2015, digestive remedies seemed to have recovered from the reverse switch of Motilium and its consequences. In 2014 the category coped with the full force of the reverse switch of the gastroprokinetic Motilium from Janssen-Cilag in December 2013; this was the leading brand in digestive remedies. The OTC to Rx switch of a brand that...

Digestive Remedies in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

DIGESTIVE REMEDIES IN BELGIUM

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2011-2016
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Digestive Remedies: % Value 2012-2016
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2013-2016
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2016-2021
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Janssen-cilag NV in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 1 Janssen-Cilag NV: Key Facts
Summary 2 Janssen-Cilag NV: Operational Indicators
Competitive Positioning
Summary 3 Janssen-Cilag NV: Competitive Position 2016
Omega Pharma Belgium NV in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 4 Omega Pharma Belgium NV: Key Facts
Summary 5 Omega Pharma Belgium NV: Operational Indicators
Competitive Positioning
Summary 6 Omega Pharma Belgium NV: Competitive Position 2016
Tilman SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 7 Tilman SA: Key Facts
Competitive Positioning
Summary 8 Tilman SA: Competitive Position 2016
Executive Summary
Detrimental Impact of the Weather and the Economy
Local Distrust and Constraints Continue To Hamper Sales
Multinationals Lead, But Do Not Perform As Well As Domestic Players
Beginning of Change in Distribution, Which Is Still Controlled by Chemists/pharmacies
Possible Ongoing Loss of Momentum for Consumer Health
Key Trends and Developments
the Belgian Economy and Consumer Health Run Into the Sand From 2015
Restrictive Legislation and Scandals Create Doubt, But Favour Alternatives
Possible Changes in Distribution Could Favour Branding and Change the Competitive Landscape
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 8 Life Expectancy at Birth 2011-2016
Market Data
Table 9 Sales of Consumer Health by Category: Value 2011-2016
Table 10 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 11 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 12 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 9 OTC: Switches 2014-2016
Definitions
Sources
Summary 10 Research Sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.